ZAZZI MAURIZIO | Professor page

Clemente, T., Torkjazi, G., Capra, N., Gagliardini, R., Cattelan, A.M., Lolatto, R., et al. (2026). Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 81(1) [10.1093/jac/dkaf415]. - view more
Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - view more
Martina, M.G., Vagaggini, C., Dreassi, E., De Angelis, M., Nencioni, L., Dragoni, F., et al. (2025). Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-14001-3]. - view more
Armenia, D., Marchegiani, G., Spagnuolo, V., Bellocchi, M.C., Galli, L., Clemente, T., et al. (2025). Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(11), 3101-3106 [10.1093/jac/dkaf349]. - view more
Papaioannu Borjesson, R., Diotallevi, S., Lolatto, R., Cenderello, G., Comi, L., Cascio, A., et al. (2025). Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(9), 2369-2374 [10.1093/jac/dkaf211]. - view more

All publications